Skip to main content
Equibles

Caption Management, LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1706766 OKLAHOMA CITY, OK
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$651,036 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Jun 30, 2026
CallValue
$6,364,743
CallShares
326,900
PutValue
$2,509,683
PutShares
128,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in MLTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,509,683 128,900
2026-06-30 $6,364,743 326,900
2025-09-30 $2,833,584 395,200
2025-09-30 $651,036 90,800
2025-09-30 $1,791,066 249,800
2025-06-30 $281,736 5,969
2025-06-30 $13,957,040 295,700
2025-06-30 $10,794,640 228,700
2025-03-31 $1,172,100 30,000
2025-03-31 $5,415,102 138,600
2024-12-31 $669,889 12,371
2024-03-31 $2,179,982 43,400
2024-03-31 $1,255,750 25,000
2023-12-31 $4,499,055 74,500
2023-12-31 $12,078,000 200,000
2023-12-31 $4,529,250 75,000
2023-09-30 $21,711,300 380,900
2023-09-30 $401,451 7,043